Linical Blog

New Webinar: Understanding the role of Non-Interventional Studies (NIS) in the generation of Real World Evidence: Efficient and quality delivery of NIS Read more...

Author: Linical Post
Linical will be exhibiting at OCT DACH on November 30th and December 1st 2022 in Munich (Holiday Inn Munich - City Centre). Read more...

Author: Linical Post
Artificial intelligence in Oncology Drug Discovery 2. Current AI applications, innovations and resources available to the industry for drug discovery in oncology. AI has the potential to shorten the path to a clinical molecule. The aim is to design and develop novel, precision engineered drugs with an improved probability of Read more...

Author: Linical Post
Linical will be at Outsourcing in Clinical Trials and Clinical Trial Supply Nordics 2022 (October 25th and 26th) in Copenhagen. Read more...

Author: Linical Post
Artificial intelligence in Oncology Drug Discovery. 1.- Understanding the current possibilities and expectations of drug discovery in oncology. AI has become increasingly relevant within the pharmaceutical industry, with $13.8B invested in companies and partnerships leveraging AI in drug discovery in a consolidating AI-enabled industry Read more...

Author: Linical Post
Recruitment at PRS: finding the right talent for the right client in the right time. An experienced and specialised recruitment process is one of the key elements to ensure the success of resource outsourcing strategies Read more...

Author: Linical Post